Long-Acting HIV Medicines and the Pandemic Inequality Cycle — Rethinking Access

A new era of long-acting antiretrovirals for HIV treatment and prevention demands a nonlinear approach to global access with faster sharing of technology, decentralized production, and products that meet needs in the Global South.

​   The New England Journal of Medicine: Search Results in Infectious Disease